|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Deferred income tax expense | |||||
| Accretion of investment discounts, net | |||||
| Gain on sale of investment securities, net | |||||
| Provision for credit losses | |||||
| Change in cash surrender value of bank-owned life insurance | |||||
| Depreciation, amortization and accretion, net | |||||
| Gain on sale of premises and equipment | |||||
| Additions to residential mortgage servicing rights carried at fair value | |||||
| Change in fair value residential mortgage servicing rights carried at fair value | |||||
| Change in fair value of residential mortgage servicing rights carried at fair value | |||||
| Stock-based compensation | |||||
| Net increase in equity and other investments | |||||
| Gain on investment securities, net | |||||
| Gain on sale of loans and leases, net | |||||
| Change in fair value of loans held for sale | |||||
| Origination of loans held for sale | |||||
| Proceeds from sales of loans held for sale | |||||
| Change in other assets and liabilities: | |||||
| Net decrease (increase) in other assets | |||||
| Net decrease in other liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchases of investment securities available for sale | |||||
| Proceeds from investment securities available for sale | |||||
| Purchases of restricted equity securities | |||||
| Redemption of restricted equity securities | |||||
| Net change in loans and leases | |||||
| Proceeds from sales of loans and leases | |||||
| Proceeds from Sale of Property, Plant, and Equipment | |||||
| Change in premises and equipment | |||||
| Purchases of premises and equipment, net of proceeds from sales | |||||
| Proceeds from bank-owned life insurance death benefits | |||||
| Net cash received from sale of Umpqua Investments, Inc. | |||||
| Purchase of bank-owned life insurance | |||||
| Proceeds from sale of mortgage servicing rights | |||||
| Cash received in an acquisition | |||||
| Other | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Net (decrease) increase in deposit liabilities | |||||
| Net decrease in federal funds purchased | |||||
| Net decrease in securities sold under agreements to repurchase | |||||
| Proceeds from borrowings | |||||
| Repayment of borrowings | |||||
| Repayment of subordinated debentures | |||||
| Net proceeds from issuance of common stock under ESPP | |||||
| Dividends paid on common stock | |||||
| Repurchase and retirement of common stock | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income taxes | |||||
| SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Changes in unrealized gains and losses on investment securities available for sale, net of taxes | |||||
| Changes in unrealized gains and losses on junior subordinated debentures carried at fair value, net of taxes | |||||
| Transfer of loans held for investment to loans held for sale | |||||
| Transfer of loans held for sale to loans held for investment | |||||
| Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation | |||||
| Assets acquired | |||||
| Liabilities assumed | |||||
| Net assets acquired | |||||
Loading...